levofloxacin has been researched along with Hepatitis B, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, W; Jia, B; Liu, Y; Xiong, Y | 1 |
| Ceydilek, B; Coban, S; Ekiz, F; Erden, E; Soykan, I | 1 |
2 other study(ies) available for levofloxacin and Hepatitis B, Chronic
| Article | Year |
|---|---|
Recurrent paratyphoid fever A co-infected with hepatitis A reactivated chronic hepatitis B.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Coinfection; Drug Resistance, Bacterial; Hepatitis A; Hepatitis A virus; Hepatitis B, Chronic; Humans; Levofloxacin; Male; Paratyphoid Fever; Recurrence; Salmonella paratyphi A | 2014 |
Levofloxacin-induced acute fulminant hepatic failure in a patient with chronic hepatitis B infection.
Topics: Anti-Bacterial Agents; Fatal Outcome; Female; Hepatic Encephalopathy; Hepatitis B, Chronic; Humans; Levofloxacin; Liver; Middle Aged; Ofloxacin; Respiratory Tract Infections | 2005 |